James Pursley Sells 15,000 Shares of Hinge Health (NYSE:HNGE) Stock

Hinge Health Inc. (NYSE:HNGE) President James Pursley sold 15,000 shares of the business’s stock in a transaction on Monday, March 23rd. The shares were sold at an average price of $42.26, for a total value of $633,900.00. Following the completion of the transaction, the president owned 732,104 shares of the company’s stock, valued at $30,938,715.04. This trade represents a 2.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Hinge Health Stock Up 0.0%

NYSE HNGE opened at $40.19 on Friday. The business has a 50 day moving average price of $40.71 and a two-hundred day moving average price of $46.37. The stock has a market cap of $3.17 billion and a PE ratio of -3.14. Hinge Health Inc. has a fifty-two week low of $30.08 and a fifty-two week high of $62.18.

Hinge Health (NYSE:HNGE) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.45. The business had revenue of $170.73 million for the quarter, compared to analysts’ expectations of $157.31 million. The business’s revenue was up 45.5% on a year-over-year basis.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. KeyCorp set a $55.00 target price on shares of Hinge Health in a research note on Wednesday, February 11th. Wall Street Zen raised Hinge Health from a “hold” rating to a “buy” rating in a report on Saturday, March 7th. Piper Sandler cut their price objective on Hinge Health from $71.00 to $60.00 and set an “overweight” rating on the stock in a research note on Friday, January 9th. Wells Fargo & Company began coverage on Hinge Health in a report on Thursday, January 8th. They set an “overweight” rating and a $68.00 target price on the stock. Finally, Freedom Capital upgraded Hinge Health to a “strong-buy” rating in a research report on Thursday, January 22nd. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $57.07.

Institutional Investors Weigh In On Hinge Health

A number of institutional investors have recently modified their holdings of the business. Wells Fargo & Company MN lifted its holdings in Hinge Health by 160.0% in the fourth quarter. Wells Fargo & Company MN now owns 546 shares of the company’s stock worth $25,000 after acquiring an additional 336 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new position in shares of Hinge Health during the fourth quarter valued at approximately $26,000. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Hinge Health during the third quarter valued at approximately $37,000. First Horizon Corp raised its position in shares of Hinge Health by 163.9% during the 4th quarter. First Horizon Corp now owns 855 shares of the company’s stock worth $40,000 after purchasing an additional 531 shares during the period. Finally, High Point Wealth Management LLC bought a new stake in shares of Hinge Health in the 4th quarter worth approximately $46,000.

Hinge Health Company Profile

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.